Combined GPR40 and GPR119 full agonism with K-757 and K-833 results in robust glucose lowering and modest weight loss in overweight/obese subjects with T2DM.
Saved in:
| Title: | Combined GPR40 and GPR119 full agonism with K-757 and K-833 results in robust glucose lowering and modest weight loss in overweight/obese subjects with T2DM. |
|---|---|
| Authors: | Crutchlow M; Kallyope, Inc., New York, New York, USA., Liu J; Kallyope, Inc., New York, New York, USA., Hernandez-Illas M; QPS, LLC, Miramar, Florida, USA., Zhang H; Kallyope, Inc., New York, New York, USA., Arreglado A; Kallyope, Inc., New York, New York, USA., Vance A; Kallyope, Inc., New York, New York, USA., Boisvert D; Kallyope, Inc., New York, New York, USA., Terracina G; Kallyope, Inc., New York, New York, USA., Lauring B; Kallyope, Inc., New York, New York, USA. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2025 Nov; Vol. 27 (11), pp. 6264-6274. Date of Electronic Publication: 2025 Aug 06. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.70014 |
